Eli Lilly and Company Dividend History (LLY)
Eli Lilly and Company will distribute a dividend of $1.3 per share on December 10, 2024 (6 days)
🤑 Eli Lilly and Company has distributed a total of 83 dividends from 2004 to 2024
📈 During this 20 period their dividend has seen a 266.20% increase in the payout amount
About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company with headquarters in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, a Civil War veteran, the company has grown to become one of the largest and most respected names in the pharmaceutical industry. As of 2023, the CEO is David A. Ricks, who has held the position since 2017. Eli Lilly is renowned for its innovation in developing medicines for various therapeutic areas, including diabetes, oncology, neuroscience, and immunology. The company is known for its significant contributions to medical advancements, such as the introduction of insulin as the first commercial treatment for diabetes. In 2022, Eli Lilly reported revenues of approximately $28 billion, reflecting its strong market presence and ongoing commitment to improving global health. With a focus on research and development, Eli Lilly continues to drive forward in creating breakthrough treatments that make life better for people around the world.
AbbVie Inc.
Amgen Inc.
Biogen Inc.
Incyte Corporation
Johnson & Johnson
Merck & Co., Inc.
Moderna, Inc.
Pfizer Inc.
Vertex Pharmaceuticals Incorporated
Viking Therapeutics, Inc.
Eli Lilly's weight loss drug Zepbound remains dominant in the market, with a potential competitor Amgen's MariTide failing to meet expectations in clinical trials. The article also discusses Eli Lilly's strong pipeline and the potential for Medicare and Medicaid coverage of weight loss drugs, which could further boost Eli Lilly's sales.
The Motley Fool · Published on Wed Dec 04 2024
Amgen's weight loss drug candidate MariTide faces competition from Eli Lilly's Zepbound and Novo Nordisk's Wegovy. While MariTide has a convenience advantage with monthly dosing, its efficacy and tolerability are not significantly better than the incumbents. Amgen's stock is still worth buying on the dip as MariTide could potentially fill a niche for more tolerable and convenient weight loss solutions.
The Motley Fool · Published on Sat Nov 30 2024
Billionaire investor Israel Englander's hedge fund Millennium Management has sold 8.1 million shares of Walmart, despite the retailer's strong performance during the recent macroeconomic challenges. The article suggests that Englander may be locking in profits and rebalancing his portfolio towards more high-growth opportunities.
The Motley Fool · Published on Fri Nov 29 2024Previous Payouts (83)
The most recent dividend Eli Lilly and Company paid out was on September 10, 2024 (85 days ago) for $1.3 per share
| Pay Date | Amount |
|---|---|
| September 10, 2024 | $1.3 |
| June 10, 2024 | $1.3 |
| March 8, 2024 | $1.3 |
| December 8, 2023 | $1.13 |
| September 8, 2023 | $1.13 |
| June 9, 2023 | $1.13 |
| March 10, 2023 | $1.13 |
| December 9, 2022 | $0.98 |
| September 9, 2022 | $0.98 |
| June 10, 2022 | $0.98 |
| March 10, 2022 | $0.98 |
| December 10, 2021 | $0.85 |
| September 10, 2021 | $0.85 |
| June 10, 2021 | $0.85 |
| March 10, 2021 | $0.85 |
| December 10, 2020 | $0.74 |
| September 10, 2020 | $0.74 |
| June 10, 2020 | $0.74 |
| March 10, 2020 | $0.74 |
| December 10, 2019 | $0.645 |
| September 10, 2019 | $0.645 |
| June 10, 2019 | $0.645 |
| March 8, 2019 | $0.645 |
| December 10, 2018 | $0.5625 |
| September 10, 2018 | $0.5625 |
| June 8, 2018 | $0.5625 |
| March 9, 2018 | $0.5625 |
| December 8, 2017 | $0.52 |
| September 8, 2017 | $0.52 |
| June 9, 2017 | $0.52 |
| March 10, 2017 | $0.52 |
| December 9, 2016 | $0.51 |
| September 9, 2016 | $0.51 |
| June 10, 2016 | $0.51 |
| March 10, 2016 | $0.51 |
| December 10, 2015 | $0.5 |
| September 10, 2015 | $0.5 |
| June 10, 2015 | $0.5 |
| March 10, 2015 | $0.5 |
| December 10, 2014 | $0.49 |
| September 10, 2014 | $0.49 |
| June 10, 2014 | $0.49 |
| March 10, 2014 | $0.49 |
| December 10, 2013 | $0.49 |
| September 10, 2013 | $0.49 |
| June 10, 2013 | $0.49 |
| March 8, 2013 | $0.49 |
| December 10, 2012 | $0.49 |
| September 10, 2012 | $0.49 |
| June 8, 2012 | $0.49 |
| March 9, 2012 | $0.49 |
| December 9, 2011 | $0.49 |
| September 9, 2011 | $0.49 |
| June 10, 2011 | $0.49 |
| March 10, 2011 | $0.49 |
| December 10, 2010 | $0.49 |
| September 10, 2010 | $0.49 |
| June 10, 2010 | $0.49 |
| March 10, 2010 | $0.49 |
| December 10, 2009 | $0.49 |
| September 10, 2009 | $0.49 |
| June 10, 2009 | $0.49 |
| March 10, 2009 | $0.49 |
| December 10, 2008 | $0.47 |
| September 10, 2008 | $0.47 |
| June 10, 2008 | $0.47 |
| March 10, 2008 | $0.47 |
| December 10, 2007 | $0.425 |
| September 10, 2007 | $0.425 |
| June 8, 2007 | $0.425 |
| March 9, 2007 | $0.425 |
| December 8, 2006 | $0.4 |
| September 8, 2006 | $0.4 |
| June 9, 2006 | $0.4 |
| March 10, 2006 | $0.4 |
| December 9, 2005 | $0.38 |
| September 9, 2005 | $0.38 |
| June 10, 2005 | $0.38 |
| March 10, 2005 | $0.38 |
| December 10, 2004 | $0.355 |
| September 10, 2004 | $0.355 |
| June 10, 2004 | $0.355 |
| March 10, 2004 | $0.355 |
Dividend data last updated Wed, 04 Dec 2024 23:04:19 GMT UTC